OneDigital Investment Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

OneDigital Investment Advisors’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-587	Closed	-$4.05K	–	1044
2023 Q2	$4.05K	Sell	587 -105	-15%	-$692	﹤0.01%	1009
2023 Q1	$10.9K	Buy	+692	New	+$13.6K	﹤0.01%	960
2022 Q4	–	Sell	-679	Closed	-$12K	–	867
2022 Q3	$12K	Sell	679 -1,343	-66%	-$28.8K	﹤0.01%	754
2022 Q2	$45K	Buy	2,022 +510	+34%	+$11.4K	﹤0.01%	692
2022 Q1	$42K	Buy	1,512 +438	+41%	+$15.9K	﹤0.01%	741
2021 Q4	$49K	Buy	1,074 +367	+52%	+$24.7K	﹤0.01%	776
2021 Q3	$59K	Buy	+707	New	+$58.5K	﹤0.01%	737

Other funds holding ONCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QPW

Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PPW

Pasadena Private Wealth Pasadena, California $786M AUM 19.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OneDigital Investment Advisors's ONCT Position: Q3 2023 in Review

OneDigital Investment Advisors sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2023, closing a stake of 587 shares — an estimated $4.05K sold.

OneDigital Investment Advisors first reported a position in ONCT in Q3 2021 and held it in 7 quarters. The position peaked at $59K in Q3 2021. 50 funds tracked by Wall St. Rank hold ONCT as of Q3 2023.

OneDigital Investment Advisors reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
OneDigital Investment Advisors sold 587 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $4.05K.
OneDigital Investment Advisors first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
OneDigital Investment Advisors's Oncternal Therapeutics, Inc. Common Stock position peaked at $59K in Q3 2021.
50 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2023.

Based on OneDigital Investment Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.